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Invasive aspergillosis (IA) is a leading cause of morbidity and mortality in
immunocompromised hosts. In some institutions, species of Aspergillus less
susceptible to amphotericin B than Aspergillus fumigatus are becoming more
common, making an accurate identification of species important. However, species
identification has traditionally relied on macroscopic colony characteristics and
microscopic morphology, which may require several days of culture. Additional
sub-culturing on specialized media may be required to induce conidia formation; in
some cases conidia may never form, confounding identification. Therefore, rapid,
nucleic acid-based methods that identify species of Aspergillus independent of
morphology are now being developed to augment or replace phenotypic
identification methods. The most successful methods to date have employed
polymerase chain reaction (PCR) amplification of target sequences within the
ribosomal RNA gene complex, including the 28S ribosomal subunit (D1-D2
region) and the internal transcribed spacers 1 and 2 (ITS1 and ITS2 regions). We
therefore developed a PCR-based assay to differentiate medically important species
of Aspergillus from one another, and from other opportunistic moulds and yeasts,
by employing universal, pan-fungal primers directed to conserved ribosomal genes
and species-specific DNA probes directed to the highly variable ITS2 region.
Amplicons were then detected in a simple, colorimetric enzyme immunoassay
format (PCR-EIA). DNA sequencing of the ITS1 and ITS2 regions and of the D1-
D2 region was also conducted for the differentiation of species by comparative
GenBank sequence analysis. The PCR-EIA method was found to be rapid,
sensitive, and specific for the identification and differentiation of the most
medically important species of Aspergillus. In addition, methods to identify species
of Aspergillus by comparative GenBank sequence analysis were found to be more
reliable using the ITS1 and ITS2 regions than the D1-D2 region.
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Introduction
Aspergillus fumigatus remains the most frequent
cause of invasive aspergillosis (IA) although at least
30 other species, primarily A. flavus, A. terreus, A. niger,
A. nidulans, A. ustus, and A. versicolor, have been
associated with human disease [1]. In some institutions,
A. terreus is becoming more common and is of concern
because it is less susceptible to amphotericin B than
A. fumigatus [2/4]. A. nidulans has also been reported
to be less susceptible to amphotericin B than
A. fumigatus [5]. Although a rare cause of invasive
disease, A. ustus has been reported to be resistant to
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amphotericin B while remaining susceptible to itraco-
nazole [6]. A. ustus has also been reported to be less
susceptible to voriconazole than A. fumigatus [7].
Therefore, accurate and timely identification of species
is important for the management of IA as well as for
surveillance and other epidemiological purposes.
Identification of species of Aspergillus has tradi-
tionally relied on macroscopic colony characteristics
and microscopic morphology. Unfortunately, several
days of culture may be required for the development
of specific phenotypic characteristics and conidia
formation that guide identification. Failure to form
conidia on ordinary culture media may require colo-
nies to be further sub-cultured on specialized media to
induce spore formation. In some cases, conidia never
develop, impeding identification. Therefore, rapid,
nucleic acid-based methods that identify the species
of Aspergillus, independent of morphology, are now
being developed to augment or replace phenotypic
identification.
We describe here molecular methods developed in
our laboratory for the differentiation of the most
medically important species of Aspergillus from one
another, as well as from other moulds and yeasts, by
a polymerase chain reaction-enzyme immunoassay
(PCR-EIA) and by sequencing and comparative




Isolates of each Aspergillus species, including type
culture strains, were grown on Czapek-Dox agar (Difco
Laboratories, Detroit, Mich.) for up to 14 days at 258C,
and for up to one week at 378C, to confirm their purity
and species identity using traditional macroscopic and
microscopic criteria and to generate sufficient growth
for DNA extraction.
DNA extraction and amplification
Fungal growth was transferred from the surface of a
single agar plate into a pre-cooled (/208C) sterile
ceramic mortar, overlaid with liquid nitrogen, and
ground with a sterile ceramic pestle into a fine powder.
Two ml of buffer G-2 (Genomic DNA buffer set;
Qiagen, Valencia, Calif.) containing RNase (200 mg/ml;
Sigma Chemical Company, St. Louis, Mo.) was added
to suspend the powder and the suspension was
transferred into a clean test tube. Forty-five microliters
of proteinase K solution (20 mg/ml stock solution;
Sigma) was added and the suspension was incubated
with intermittent agitation for 3 h at 558C. The
suspension was centrifuged at 21,500/g for 10 min,
the supernatant was transferred into a clean test tube,
and DNA was extracted and purified using Genomic-
tip 20/G columns (Qiagen) according to the manufac-
turer’s instructions. Two and one-half microliters
of glycogen solution (20 mg/ml; Gentra Systems,
Minneapolis, Minn.) was added to the eluted DNA
which was then precipitated by standard methods using
isopropanol and ethanol. DNA was resuspended in
60 ml of DNA rehydration buffer (PureGene kit,
Gentra Systems) and stored at /208C until used.
Detection of PCR amplicons by enzyme immunoassay
(PCR-EIA)
Universal fungal primers ITS3 (5? GCA TCG ATG
AAG AAC GCA GC) and ITS4 (5? TCC TCC GCT
TAT TGA TAT GC), directed to the internal tran-
scribed spacer 2 (ITS2) region of ribosomal DNA
(rDNA) (Fig. 1), were employed to amplify DNA from
all species of Aspergillus tested. PCR amplicons were
then detected colorimetrically as previously described
[8].
DNA sequencing
Semi-nested PCR, using universal fungal primers ITS1
(5? TCC GTA GGT GAA CCT GCG G) and D2R
(5? TTG GTC CGT GTT TCA AGA CG), followed by
primers D1 (5? GCA TAT CAA TAA GCG GAG GA)
and D2R, generated the 28S rDNA D1-D2 region
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Fig. 1 Detection of ITS2 rDNA amplicons by PCR-EIA [8].
Binding sites for universal fungal primers ITS3 and ITS4 in the
conserved 5.8S and 28S regions of rDNA are shown in step 1.
Hybridization of biotinylated and digoxigenin-labeled probes, direc-
ted to the amplicons produced after PCR amplification of the ITS2
rDNA region, is shown in step 2. After hybridization to the
amplicon, the biotin probe is captured onto streptavidin-coated
microtiter plate wells and the digoxigenin probe, hybridized adjacent
to the biotin probe, is detected spectrophotometrically (A650nm) after
addition of horseradish peroxidase-conjugated anti-digoxigenin anti-
bodies, H2O2, and a colorimetric substrate.
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ITS5 (5? GGA AGT AAA AGT CGT AAC AAG G)
and ITS2 (5? GCT GCG TTC TTC ATC GAT GC) or
ITS3 and ITS4 were used to PCR amplify rDNA
regions ITS1 and ITS2, respectively. PCR amplification
was conducted in a GeneAmp model 9700 thermal
cycler (Perkin Elmer Applied Biosystems, Foster City,
Calif.) as described previously [9]. All PCR products
were purified before DNA sequence analysis using a
QIAquick PCR Purification kit (Qiagen). Purified
amplicons were then sequenced on both strands using
the same primers as described above and BigDye
Terminator Cycle Sequencing Ready Reaction kits
(Perkin Elmer Applied Biosystems) as recommended
by the manufacturer [9]. Products were analyzed on an
automated capillary DNA sequencer (ABI Prism 310
Genetic Analyzer, Perkin Elmer Applied Biosystems)
according to the manufacturer?s directions.
Results
Universal fungal primers and species-specific DNA probes
for the identification of aspergilli
Species-specific probes for seven species of Aspergillus
(A. flavus, A. fumigatus, A. nidulans, A. niger, A. terreus,
A. ustus, and A. versicolor ) were designed after DNA
sequencing and alignment of ITS2 rDNA regions from
multiple, authenticated culture collection strains [8,9].
Unique signature sequences within each species were
identified and DNA probes were designed from these
regions (Fig. 2). Each of the seven species probes were
specific for their homologous target DNA (Table 1) and
did not cross-react with DNA from any of 34 species of
Acremonium, Candida, Exophiala, Fusarium, Mucor,
Paecilomyces, Penicillium, Rhizopus, Rhizomucor, Sce-
dosporium , or Sporothrix species that were tested [8].
These probes did not cross-react with DNA from any
of eight other species of Aspergillus tested, with two
exceptions. The A. nidulans probe cross-reacted with A.
ustus DNA, and the A versicolor probe gave minor
cross-reactivity with A. candidus DNA (i.e., the A.
versicolor probe gave a ten-fold lower colorimetric
reading with A. candidus DNA than with A. versicolor
DNA). In the first instance, although the A. nidulans
probe cross-reacted with A. ustus DNA, the A. ustus
probe did not cross-react with A. nidulans DNA (Table
1). Therefore, these two species could be differentiated
by a process of elimination. DNA sequence analysis
demonstrated the existence of unique A. candidus
signature sequences upstream from the A. versicolor
probe region that could easily be used to design a probe
specific for A. candidus DNA [9].
The limit of sensitivity for the PCR-EIA system was
found to be 0.5 pg of target DNA (equivalent to
approximately 1 to 10 conidia) compared to 5 pg of
DNA detected after agarose gel electrophoresis and
ethidium bromide staining of PCR products [8].
The limit of test sensitivity was similar to that reported
by others using PCR amplification systems and South-
ern blot detection of amplicons [10]. Therefore, the
combined use of universal, fungus-specific PCR
primers that target conserved, multi-copy genes present
in all fungal genera, followed by specific DNA
probes to identify a given species, was shown to be
highly sensitive and specific. The major advantages
of the PCR-EIA identification system, compared
to conventional phenotypic identification methods,
were:
1. it was rapid (this test could be completed in a single
day);
2. it did not require species of Aspergillus to form
specialized identifying structures such as conidia;
3. small amounts of DNA target could be detected
(picogram quantities);
4. DNA probes could be easily and reproducibly
synthesized and stored ready for use;
5. DNA probes were very specific;
6. interpretation of the results were objective (colori-
metric, spectrophotometric readout);
7. the detection system has the potential to be easily
automated.
DNA sequencing and comparative GenBank data analysis
Although the PCR-EIA method was found to be highly
sensitive and specific, probes were designed to detect
only seven of the 30 known species of Aspergillus
associated with human disease. It was hypothesized
that DNA sequence analysis, using universal fungal
primers and comparative GenBank searches, might
provide specific identification of a larger number of
Aspergillus species than DNA probes. However, this
would require use of appropriate DNA target regions
that display sufficient interspecies sequence variation,
without excessive intraspecies variation. DNA target
regions that have been examined for such purposes
include an aflatoxin pathway regulatory gene [11,12],
the b-tubulin gene [13], and various ribosomal RNA
(rRNA) regions [14/17]. In addition, the variable
regions at the 5? end of the 28S rRNA gene (the D1-
D2 region) and the internal transcribed spacer regions
1 and 2 (ITS1 and ITS2) of rDNA have each been
examined by others as sequencing targets [18/22].
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However, because there had been no systematic
assessment or comparison of the rDNA regions for
their utility as diagnostic targets for the identification
of medically important species of Aspergillus, we
sequenced the ITS1, ITS2, and D1-D2 rDNA regions
of 13 medically important species (A. candidus, A.
[Eurotium] chevalieri , A. [Fennellia] flavipes, A.
flavus, A. fumigatus, A. granulosus, A. [Emericella]
nidulans, A. niger, A. restrictus, A. sydowii , A. terreus,
A. ustus, and A. versicolor). Sequencing results were
used to examine amplicon length, to conduct pairwise
nucleotide sequence comparisons and DNA align-
ments, and to perform comparative GenBank data
analyses for the identification and differentiation of the
species under study [9].
Analysis of DNA sequence length polymorphisms
No significant differences in the length of the D1-D2
region were observed among any of the 13 species of
Aspergillus examined (all species were 542 bp in length
except for A. nidulans which was 543 bp in length) [9].
In contrast, sequences for the ITS1 region ranged in
length from 142 nt (A. chevalieri ) to 186 nt (A. terreus ).
Sequence length was more variable among the aspergilli
in the ITS1 region than in the D1-D2 region; i.e., in
the ITS1 region, five of the 13 species studied demon-
strated a unique sequence length (A. candidus,
A. chevalieri, A. granulosus, A. nidulans, and A. terreus )
compared to only one species (A. nidulans ) in the D1-
D2 region. Identical or similar sequence lengths were
observed for A. candidus, A. flavus, and A. restrictus
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Fig. 2 Design of Aspergillus species-specific oligonucleotide probes for PCR-EIA. DNA sequencing of the ITS2 rDNA region for selected
Aspergillus species was conducted and sequences were aligned and compared [9]. Unique signature sequences (i.e., those that were recognized to
occur consistently among strains of a given species) located at the 3’ end of the ITS2 variable region 2 were used to design species-specific
oligonucleotide probes. For example, the box at the bottom of the figure identifies a signature sequence, unique to strains of A. terreus, that was
used to design an A. terreus -specific PCR-EIA probe.
Table 1 Specificity of ITS2 region oligonucleotide probes to detect Aspergillus species DNA by PCR-EIA. Adapted from de Aguirre et al . [8]
Target DNA Mean A650nm using oligonucleotide probe for:
A. flavus A. fumigatus A. nidulans A. niger A. terreus A. ustus A. versicolor
A. flavus 1.73 0a 0 0 0 0 0
A. fumigatus 0 2.37 0 0 0 0 0
A. nidulans 0 0 0.87 0 0 0 0
A. niger 0 0 0 1.24 0 0 0
A. terreus 0 0 0 0 1.51 0 0
A. ustus 0 0 0.55 0 0 1.41 0
A. versicolor 0 0 0 0 0 0 1.64
a Mean A650nm9/SE for all heterologous Aspergillus species DNA tested: 0.0049/0.003.
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(180/181 nt), A. flavipes, A. fumigatus, A. niger, and
A. terreus (184/186 nt), and A. granulosus, A. nidulans,
A. sydowii , A. ustus, and A. versicolor (153/156 nt) [9].
In comparison, ITS2 sequences varied in length from
160 nt (A. flavipes ) to 177 nt (A. terreus ). Sequence
length was slightly less variable among the Aspergillus
spp. in the ITS2 than in the ITS1 region but was more
so than in the D1-D2 region. For example, three of the
13 species examined demonstrated a unique sequence
length in the ITS2 region (A. chevalieri, A. granulosus,
and A. terreus ), and five shared identical sequence
length with at least one strain from each of the
13 species examined (e.g., A. chevalieri and A.
versicolor, 167 nt). Identical or similar sequence lengths
were observed for A. candidus, A. chevalieri , A. flavus,
A. fumigatus, A. nidulans, A. niger, A. sydowii , and
A. versicolor (167/169 nt), and among A. granulosus,
A. restrictus, and A. ustus (170/172 nt). However,
combining data for both the ITS1 and ITS2 regions,
including or excluding the intervening conserved 5.8S
region, allowed all 13 species examined to be differ-
entiated from one another (ITS1/ITS2 sequence
length). The only exceptions were for A. candidus
(505 nt) and one non-type strain of A. flavipes
(A. flavipes I; 505 nt) and for a non-type strain of
A. nidulans (A. nidulans II, 480 nt) and A. sydowii.
These data reflect comparisons among the 13 species of
Aspergillus selected. Sequence length comparisons
among molecular siblings of these species may prove
less discriminatory and this will become more obvious
below. In general, the sequence length of any ribosomal
region alone could not be reliably used to differentiate
among all species examined. However, the greatest
degree of discrimination among species was obtained
using combined ITS1 and ITS2 sequence data [9].
Pairwise nucleotide sequence comparisons
Pairwise nucleotide sequence comparisons within the
D1-D2 region demonstrated differentiation of the most
medically important species to at least the group level,
although some closely related species shared greater
than 99% sequence identity (i.e., A. granulosus versus
A. ustus and A. sydowii versus A. versicolor ). In
contrast, none of the species examined demonstrated
sequence identities of greater than 99% in either the
ITS1 or ITS2 regions, irrespective of phylogenetic
relatedness [9]. Interspecies sequence identities ranged
from 91.9% to 99.6% for the D1-D2 region, from 57.4%
to 98.1% for the ITS1 region, and from 75.6% to 98.3%
for the ITS2 region (Table 2).
Intraspecies variability was minimal in the D1-D2
region; strains differed by 0 nt for all species examined
except for strains of A. flavipes, A. sydowii , and
A. nidulans, which differed by 1/2 nt from their
respective type strains. In contrast, sequence variability
from the type strain of 1/14 nucleotides (1 nt,
A. nidulans ; 14 nt, A. ustus ) occurred among strains
of A. niger, A. flavipes, A. ustus, A. sydowii , and
A. nidulans in the ITS1 region. Differences of
1/8 nucleotides (1 nt, A. niger and A. nidulans ; 8 nt,
A. flavipes ) occurred among strains of these same
species in the ITS2 region (Table 2). Therefore, the rank
order for the greatest to least interspecies differences
(most species variability) was ITS1/ITS2/D1-D2
and the rank order for the least to greatest intra-
species divergence (least strain variability) was D1-
D2B/ITS2B/ITS1. It is not known if the observed
intraspecies differences are an artifact of current
taxonomy or if these strains represent true sequevars
(i.e., a sequevar is a group of strains with sequences that
are identical to one another but which vary from those
of other strains within the same species).
DNA sequence alignments and comparative GenBank data
searches
DNA sequence alignments revealed greater sequence
variability among species of Aspergillus in the D2 than
in the D1 region of rDNA whereas even greater
differences were observed in five variable ITS1 and
two variable ITS2 regions [9]. Comparative GenBank
data searches demonstrated that D1-D2 sequences
rarely allowed unambiguous differentiation of closely
related species; 10 of 13 Aspergillus species examined
showed 5/1 nt sequence divergence from organisms
catalogued in GenBank as a different species. In
contrast, only five of the species examined exhibited
5/1 nt divergence with a different species in their ITS1
or ITS2 sequences. For example, a GenBank query
using A. flavus sequences matching those of the type
strain for A. flavus in all three rDNA regions examined
gave 100% identity with five molecular siblings in the
Table 2 Comparative variation between species and within species
as assessed by pairwise nucleotide sequence alignment of rDNA
regions








a Percent sequence identity among different species of Aspergillus.
b Variability between strains within a given species as measured by the
number of nucleotide (nt) differences from the type strain sequence.
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D1-D2 region and only one molecular sibling in each of
the ITS1 and 2 regions (Table 3; molecular siblings are
defined in footnote b). Furthermore, only four of the
species examined (A. chevalieri , A. flavus, A. nidulans,
and A. niger ) shared identical sequences with other
species in both ITS regions [9]. The current GenBank
database does not contain ITS sequences for all species
(designated in Table 3 as ‘‘NA’’ / not currently
available), and major improvement of GenBank data
in terms of sequence quality and annotation is needed.
Therefore, at present, the identification of medically
important aspergilli using comparative GenBank se-
quence analysis seems more reliable using combined
ITS1-ITS2 sequence data rather than D1-D2 se-
quences. It is important to note that the sequence
identities reported here are those obtained with a
limited number of strains. It is possible that sequence
identities between medically important species and
their molecular siblings may be as high as 100% in
any of the rDNA regions examined for strains that were
not examined in this study. Also, because molecular
taxonomic structure is under construction, it is not
known if changes in traditional phenotypic classifica-
tion may occur in the future, which would alter the
interpretation of the above results.
Discussion
Species of Aspergillus shown to be less susceptible to
amphotericin B than A. fumigatus are becoming
important in some institutions [2,3,6]. For example,
A. terreus has been reported to account for 16% of IA
cases in hematopoietic stem cell transplant recipients
and was responsible for almost 12% of cases in solid
organ transplant patients [23]. Therefore, rapid and
accurate identification of the infecting species has
become particularly important for the implementation
of appropriate antifungal therapy, as well as for
epidemiologic purposes. Currently, phenotypic meth-
ods for the identification of the most common aspergilli
remain useful in the clinical microbiology laboratory.
Less common species are referred to reference labora-
tories for identification as are atypical or non-conidiat-
ing isolates. Because species of Aspergillus are
ubiquitous, not every isolate received in a clinical
laboratory needs to be identified to species. However,
if an isolate is linked to a high-risk patient or is
collected in conjunction with suspected invasive dis-
ease, species identification may help guide clinical
management. In addition, information about species
identity is important for epidemiologic purposes, such
as for outbreak investigations, surveillance for the
emergence of new species causing disease, and an
accurate determination of incidence rates. In such
cases, species-specific probes, particularly in a micro-
array format, would be useful for the rapid screening of
a large number of samples.
Microarray formats provide the advantages of re-
quiring only a small amount of PCR amplicon for a
large amount of data retrieved (hundreds of probes can
be included in a single run), data retrieval and analysis
is rapid and can be automated, and the cost can be
minimal if glass slides are manufactured in-house. A
prototype microarray, constructed in our laboratory for
the differentiation of multiple species of Aspergillus, as
well as for the differentiation of species of Candida,
Fusarium , Scedosporium and some zygomycetes, is
currently being evaluated and developed for commer-
cialization. Microarrays have been designed elsewhere
for identifying bacteria [24] and are under development
for identifying and differentiating species of Candida
[25]. Both the D2 region of 28S rDNA [26] and the
ITS1 and ITS2 regions [8,27] have been used to design
species-specific diagnostic probes. Probes directed to
Table 3 Molecular siblings identified for Aspergillus flavus by a comparative GenBank database search. Adapted from Hinrikson et al . [9]a
Query sequencea Molecular siblingsb Maximum sequence identity as percent of targetc
D1-D2 ITS1 ITS2
A. flavus A. oryzae 100.0 100.0 100.0
A. parasiticus 100.0 97.8 97.7
A. sojae 100.0 97.8 97.7
A. tamari 99.8 95.6 97.7
A. subolivaceus 100.0 NAd NA
A. terricola 100.0 NA NA
A. flavofurcatus 99.8 NA NA
a Reference strain with identical D1-D2, ITS1, and ITS2 sequences compared to the type strain.
b Organisms assigned in GenBank to a different species than query sequence although exhibiting identical or very similar (/99% identity)
sequences in at least one ribosomal region examined.
c Comparative identity between query sequence and reference sequences of molecular siblings in the GenBank database.
d NA/no corresponding reference data available for this molecular sibling in the ITS region at the time of this study.
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the D2 region identify most species to the traditional
(phenotypic) or phylogenetic group level as defined by
Raper and Fennell [28] and Peterson [18], respectively,
whereas the ITS probes may identify distinct species.
Some intraspecies variability was noted in the ITS
regions, but it is not known if this represents differences
between phenotypic and molecular taxonomic struc-
ture as reported for other genera [29] or if true
sequevars exist within a species. In any case, both
probe methods and microarray methods require known
sequence information for the design of specific probes
for a given detection format or array.
A broader approach, which would capture known as
well as unknown species, would be to apply universal
DNA sequence analysis. However, universal DNA
sequence analysis has several limitations, as demon-
strated by our work, particularly when public databases
are being used as the source of reference information.
Currently available public databases are not refereed
and their quality is solely dependent on the accuracy of
the submitter. Commercial databases are becoming
available but are currently expensive and incomplete
or are not in concordance with phenotypic identifica-
tion results. A recent study reported only 50%/60% of
the molecular identifications were concordant with the
results of phenotypic methods [30]. The lack of
concordance between methods in this study was partly
attributed to the incompleteness of the sequence
database. Other questions, concerning the impact of
molecular identification on traditional taxonomic
structure, remain unresolved at present. Complete
evaluation of future databases will need to rely on a
uniform, standardized molecular taxonomic structure.
A true species definition will be needed and may not be
easily assessed on the basis of percent sequence
homology for ribosomal genes alone. Other methods,
or combinations of methods [31,32], such as genomic
DNA-DNA complementarity measurements, isoen-
zyme studies, and DNA sequence analysis of multiple
genes, may be required. Taxonomic structure will very
much depend on what DNA region or regions are
chosen for sequence analysis. For example, the more
conserved 18S and 28S regions tend to combine more
closely related species into the same taxonomic group,
whereas more variable regions such as the ITS regions
tend to split groups into distinct species. Ideally,
multiple regions, reflecting the true evolution of a
species, will be discovered and all regions will provide
concordant findings. Different molecular targets may
provide varying degrees of differentiation, depending
on the organisms under study, and targets may need to
be tailored for optimum results. Sequences for the
rRNA intergenic spacer (IGS) and ITS regions [32] or
sequences for the 28S rRNA gene, a portion of the
elongation factor-1 alpha gene, and a combination of
both of the latter genes have been used to differentiate
species of Fusarium [33/35]. Other molecular targets,
or even other genotyping methods, may be necessary
for optimal identification and differentiation of some
species. In addition, the difficulty of defining a species
is made all the more complex because many of the
organisms under study have no known sexual state.
Species definitions based on a biologic concept (genetic
crosses) become impossible or, at the very least,
impractical.
Despite the limitations described above, molecular
methods for the identification of species of Aspergillus
and of other medically important fungi will no doubt
expand rapidly in the near future. Automated technol-
ogies combining extraction of microbial DNA from
clinical materials, DNA amplification, and amplicon
detection within a single, closed system are currently
under commercial development for fungal pathogens
[36] and automated systems are in use in many clinical
laboratories for the detection of viral and bacterial
pathogens [37,38]. Pan-microbial microarrays, particu-
larly syndromic arrays (i.e., meningitis, respiratory, or
septicemia arrays) for fungal as well as bacterial agents
would provide the greatest amount of information and
require the least amount of target DNA per assay. Such
arrays are already in development for the identification
of the most common bacteria causing urinary tract [39]
and bloodstream infections [40]. At a minimum, the
PCR-EIA system has been shown to have clinical
utility for the detection of DNA from species of
Candida recovered from blood culture bottles [41]
and for the detection of DNA from species of
Aspergillus recovered from tissue in an experimental
model of aspergillosis [8]. At the same time, larger and
more accurate DNA databases emanating from public,
private, and commercial sectors will become available.
Improved DNA sequence information, in conjunction
with other identification methods, will enable the
establishment of a standardized, objective taxonomic
structure for the classification of fungi. The impact of
such advances in molecular identification methods on
clinical outcome is yet to be determined but should
ultimately lead to improved diagnosis, therapy, and
management of fungal diseases, including invasive
aspergillosis.
References
1 de Hoog GS, Guarro J, Gene J, Figueras MJ. Atlas of Clinical
Fungi , 2nd edn. Utrecht: Centralbureau voor Schimmelcultures,
2000.
– 2005 ISHAM, Medical Mycology, 43, S129/S137
Molecular identification of Aspergillus species S135
2 Baddley JW, Pappas PG, Smith AC, Moser SA. Epidemiology of
Aspergillus terreus at a university hospital. J Clin Microbiol 2003;
41: 5525/5529.
3 Iwen PC, Rupp ME, Langnas AN, Reed EC, Hinrichs SH.
Invasive pulmonary aspergillosis due to Aspergillus terreus : 12-
year experience and review of the literature. Clin Infect Dis 1998;
26: 1092/1097.
4 Sutton DA, Sanche SE, Revankar SG, Fothergill AW, Rinaldi RG.
In vitro amphotericin B resistance in clinical isolates of Aspergillus
terreus, with head-to-head comparison to voriconazole. J Clin
Microbiol 1999; 37: 2343/2345.
5 Kontoyiannis DP, Lewis RE, May GS, Osherov N, Rinaldi MG.
Aspergillus nidulans is frequently resistant to amphotericin B.
Mycoses 2002; 45: 406/407.
6 Iwen PC, Rupp ME, Bishop MR, et al . Disseminated aspergillosis
caused by Aspergillus ustus in a patient following allogenic
peripheral stem cell transplantation. J Clin Microbiol 1998; 36:
3713/3717.
7 Verweij PE, van den Bergh MFQ, Rath PM, et al . Invasive
aspergillosis caused by Aspergillus ustus : case report and review. J
Clin Microbiol 1999; 37: 1606/1609.
8 de Aguirre L, Hurst SF, Choi JS, et al . Rapid differentiation of
Aspergillus species from other medically important opportunistic
molds and yeasts by PCR-enzyme immunoassay. J Clin Microbiol
2004; 42: 3495/3504.
9 Hinrikson HP, Hurst SF, Lott TJ, Warnock DW, Morrison CJ.
Assessment of ribosomal large-subunit D1-D2, internal tran-
scribed spacer 1, and internal transcribed spacer 2 regions as
targets for molecular identification of medically important
Aspergillus species. J Clin Microbiol 2005; in press.
10 Einsele H, Hebart H, Roller G, et al . Detection and identification
of fungal pathogens in blood by using molecular probes. J Clin
Microbiol 1997; 35: 1353/1360.
11 Varga J, Rigo K, Molnar J, et al . Mycotoxin production and
evolutionary relationships among species of Aspergillus section
Clavati . Antonie van Leeuwenhoek 2003; 83: 191/200.
12 Geiser DM, Dorner JW, Horn BW, Taylor JW. The phylogenetics
of mycotoxin and sclerotium production in Aspergillus flavus and
Aspergillus oryzae. Fungal Genet Biol 2000; 31: 169/179.
13 Varga J, Toth B, Rigo K, Debets F, Kozakiewicz Z. Genetic
variability within the Aspergillus viridinutans species. Folia
Microbiol (Praha) 2000; 45: 423/428.
14 Wu Z, Tsumura Y, Blomquist G, Wang X-R. 18S rRNA gene
variation among common airborne fungi and development of
specific oligonucleotide probes for the detection of fungal isolates.
Appl Envirn Microbiol 2003; 69: 5389/5397.
15 Chang J-M, Oyaizu H, Sugiyama J. Phylogenetic relationships
among eleven selected species of Aspergillus and associated
teleomorphic genera estimated from 18S ribosomal RNA partial
sequences. J Gen Appl Microbiol 1991; 37: 289/308.
16 White TJ, Burns TD, Lee SB, Taylor JW. Amplification and direct
sequencing of fungal ribosomal RNA genes for phylogenetics. In:
Innis MA, Helfand DH, Sninsky JJ, White TJ (eds). PCR
Protocols. San Diego, CA: Academic Press, Inc., 1990: 315/322.
17 Rigo K, Varga J, Toth B, et al . Evolutionary relationships within
Aspergillus section Flavi based on sequences of the intergenic
transcribed spacer regions and the 5.8S rRNA gene. J Gen Appl
Microbiol 2002; 48: 9/16.
18 Peterson SW. Phylogenetic relationships in Aspergillus based on
rDNA sequence analysis. In: Samson RA, Pitt JI (eds). Integration
of modern taxonomic methods for Penicillium and Aspergillus
classification . Amsterdam, the Netherlands: Harwood Academic
Publishers, 2000: 323/355.
19 Varga J, Toth B, Rigo K, et al . Phylogenetic analysis of
Aspergillus section Circumdati based on sequences of the internal
transcribed spacer regions and the 5.8 S rRNA gene. Fungal Genet
Biol 2000; 30: 71/80.
20 Turenne CY, Sanche SE, Hoban DJ, Karlowsky JA, Kabani AM.
Rapid identification of fungi by using the ITS2 genetic region and
an automated fluorescent capillary electrophoresis system. J Clin
Microbiol 1999; 37: 1846/1851.
21 Henry T, Iwen PC, Hinrichs SH. Identification of Aspergillus
species using internal transcribed spacer regions 1 and 2. J Clin
Microbiol 2000; 38: 1510/1515.
22 Pryce TM, Pallidino S, Kay D, Coombs GW. Rapid identification
of fungi by sequencing the ITS1 and ITS2 regions using an
automated capillary electrophoresis system. Med Mycol 2003; 41:
369/381.
23 Morgan J, Wannemuehler KA, Marr KA, et al . Incidence of
invasive aspergillosis following hematopoietic stem cell and solid
organ transplantation: interim results of a prospective multicenter
surveillance program. Med Mycol 2005; 43(suppl 1): 49/58.
24 Anthony RM, Brown TJ, French GL. Rapid diagnosis of
bacteremia by universal amplification of 23S ribosomal DNA
followed by hybridization to an oligonucleotide array. J Clin
Microbiol 2000; 38: 781/788.
25 Varnier OE, Bertolotti F, Ferrari D, et al . Rapid identification of
Candida species using a non-fluorescent DNA-based biochip. In:
Program Abstracts of the 44th Annual Interscience Conference on
Antimicrobial Agents and Chemotherapy, Washington, D.C.,
October 30/November 2, 2004. Washington, DC: American
Society for Microbiology, 2004: D-463.
26 Sandhu G, Kline BC, Stockman L, Roberts GD. Molecular
probes for diagnosis of fungal infections. J Clin Microbiol 1995;
33: 2913/2919.
27 Martin C, Roberts D, van Der Weide M, et al . Development of a
PCR-based line probe assay for identification of fungal pathogens.
J Clin Microbiol 2000; 38: 3735/3742.
28 Raper KB, Fennell DI. The genus Aspergillus. Baltimore: Williams
& Wilkins, 1965.
29 O’Donnell K, Cigelnik E. Two divergent intragenomic rDNA
ITS2 types within a monophyletic lineage of the fungus Fusarium
are nonorthologous. Mol Phylogenet Evol 1997; 7: 103/116.
30 Hall L, Wohlfiel S, Roberts GD. Experience with the MicroSeq
D2 large-subunit ribosomal DNA sequencing kit for identification
of filamentous fungi encountered in the clinical laboratory. J Clin
Microbiol 2004; 42: 622/626.
31 Parenicova L, Skouboe P, Frisvad J, et al . Combined molecular
and biochemical approach identifies Aspergillus japonicus and
Aspergillus aculeatus as two species. Appl Environ Microbiol 2001;
67: 521/527.
32 Schmidt H, Adler A, Holst-Jensen A, et al . An integrated
taxonomic study of Fusarium langsethiae, Fusarium poae and
Fusarium sporotrichioides based on the use of composite datasets.
Int J Food Microbiol 2004; 95: 341/349.
33 Hennequin C, Abachin E, Symoens F, et al . Identification of
Fusarium species involved in human infections by 28S rRNA gene
sequencing. J Clin Microbiol 1999; 37: 3586/3589.
34 Knutsen AK, Torp M, Holst-Jensen A. Phylogenetic analyses of
the Fusarium poae, Fusarium sporotrichioides and Fusarium
langsethiae species complex based on partial sequences of the
translation elongation factor-1 alpha gene. Int J Food Microbiol
2004; 95: 287/295.
35 Healy M, Walton D, Reece K, et al . Identification and molecular
typing of clinical Fusarium isolates by two DNA sequencing
methods and automated rep-PCR. In: Program Abstracts of the
– 2005 ISHAM, Medical Mycology, 43, S129/S137
S136 Hinrikson et al.
44th Annual Interscience Conference on Antimicrobial Agents and
Chemotherapy, Washington, DC, October 30/November 2, 2004.
Washington, DC: American Society for Microbiology, 2004: D-
465.
36 Loeffler J, Schmidt K, Hebart H, Schumacher U, Einsele H.
Automated extraction of genomic DNA from medically impor-
tant yeast species and filamentous fungi by using the MagNA
Pure LC system. J Clin Microbiol 2002; 40: 2240/2243.
37 Caliendo AM, Ingersoll J, Green AM, Nolte FS, Easley KA.
Comparison of the sensitivities and viral load values of the
amplicor HIV-1 monitor version 1.0 and 1.5 tests. J Clin
Microbiol 2004; 42: 5392/5393.
38 Bianchi AB, Moret F, Desrues J-M, et al . PreservCyt transport
medium used for the ThinPrep pap test is a suitable medium for
detection of Chlamydia trachomatis by the COBAS Amplicor CT/
NG test: results of a preliminary study and future implications. J
Clin Microbiol 2002; 40: 1749/1754.
39 Rautakorpi H, Jalava J, Roth S, Nikkari S. Bacterial gyrB/pare
PCR based microarray analysis from urine. In: Program Abstracts
of the 44th Annual Interscience Conference on Antimicrobial Agents
and Chemotherapy, Washington, DC, October 30/November 2,
2004. Washington, DC: American Society for Microbiology, 2004:
D-482.
40 Roth SB, Jalava J, Lindfors M, Meurman O, Nikkari
S. Identification of bacteria from positive blood cultures with
an oligonucleotide array. In: Program Abstracts of the 44th
Annual Interscience Conference on Antimicrobial Agents and
Chemotherapy, Washington, DC, October 30-November 2, 2004.
Washington, DC: American Society for Microbiology, 2004: D-
481.
41 Shin J-H, Nolte FS, Morrison CJ. Rapid identification of Candida
species in blood cultures by a clinically useful PCR method. J Clin
Microbiol 1997; 35: 1454/1459.
– 2005 ISHAM, Medical Mycology, 43, S129/S137
Molecular identification of Aspergillus species S137
